Good Manufacturing Practice (GMP): Requirements, Regulations, and Quality Systems

What Good Manufacturing Practice Means

Good Manufacturing Practice refers to a structured set of operational and quality controls designed to ensure products meet regulatory safety and quality requirements.

GMP focuses on how products are manufactured, not simply whether finished goods meet specifications. Testing a sample cannot prove that every unit in a batch is acceptable; a controlled, documented process can.

Core GMP principles include:

• Controlled manufacturing environments

• Documented procedures and work instructions

• Qualified and trained personnel

• Validated equipment and processes

• Traceable materials and batch records

• Independent quality oversight

• Corrective and preventive action systems

• Continuous monitoring and improvement

These controls reduce risks associated with contamination, mix-ups, labeling errors, and inconsistent manufacturing processes.

Organizations seeking structured governance often combine GMP programs with formal management systems through ISO consulting services to strengthen audit readiness and operational consistency.

The Five Ps of GMP

Quality professionals often summarize GMP requirements as the "five Ps," a practical way to confirm that no part of the operation is left uncontrolled:

• People: Everyone who affects product quality is qualified, trained for their role, and follows hygiene and gowning requirements.

• Premises: Facilities and equipment are designed, cleaned, maintained, and calibrated to prevent contamination and mix-ups.

• Processes: Manufacturing processes are defined, validated, and controlled, and changes are evaluated before they are made.

• Products: Materials and products meet specifications from receipt of raw materials through release and distribution.

• Procedures: Written procedures and records show what should happen and prove what did happen, batch by batch.

The five Ps are a teaching framework rather than a regulation, but the GMP regulations below address each of these areas.

GMP Regulations in the U.S. and Internationally

GMP requirements are established by regulatory authorities and vary by product type and jurisdiction. The underlying principles are consistent; the specific rules, terminology, and inspection practices differ.

U.S. FDA GMP Regulations

In the United States, the Food and Drug Administration (FDA) enforces CGMP through product-specific regulations in Title 21 of the Code of Federal Regulations:

• Drugs: 21 CFR Parts 210 and 211 govern finished pharmaceuticals. See Pharmaceutical GMP Compliance and FDA Drug Manufacturing for how these requirements apply to drug manufacturers.

• Medical devices: 21 CFR Part 820 is now the Quality Management System Regulation (QMSR), effective February 2, 2026. It replaced the former Quality System Regulation (QSR) and incorporates ISO 13485:2016 by reference. Device manufacturers working through the transition can start with our FDA QMSR Consultant services.

• Dietary supplements: 21 CFR Part 111 governs Dietary Supplement GMP for manufacturing, packaging, labeling, and holding operations.

• Human food: 21 CFR Part 117 sets CGMP and preventive controls requirements for food facilities.

• Biologics: 21 CFR Parts 600–680 add biologics-specific requirements alongside the drug CGMP regulations.

International GMP Frameworks

Organizations that manufacture for or export to other markets must also meet regional requirements, including:

• EU GMP: EudraLex Volume 4, the GMP guidelines for medicinal products in the European Union.

• PIC/S GMP Guide: used by the inspectorates participating in the Pharmaceutical Inspection Co-operation Scheme and closely aligned with EU GMP.

• WHO GMP: World Health Organization guidelines adopted or referenced by many national regulators.

• ICH Q7: GMP guidance for active pharmaceutical ingredients.

• ISO 22716: the international GMP guideline for cosmetics.

Each framework sets requirements for documentation, process validation, facility controls, equipment maintenance, and quality management oversight. Companies frequently engage a Regulatory Compliance Consulting partner to interpret overlapping expectations and design one quality system that satisfies every market they serve.

Why Good Manufacturing Practice Exists

GMP regulations exist to protect public health by ensuring that products are manufactured under controlled conditions.

Without structured manufacturing controls, organizations face risks such as:

• Contaminated products entering the market

• Incorrect formulation or dosage

• Labeling errors

• Product mix-ups between batches

• Untraceable supply chain materials

• Inadequate testing and release controls

Regulators therefore require manufacturers to prove that their processes consistently produce safe and effective products.

Strong GMP systems demonstrate that quality is built into the process, not inspected only at the end.

Organizations frequently align GMP programs with broader operational governance initiatives such as Enterprise Risk Management to ensure manufacturing risks are evaluated within overall corporate risk frameworks.

Core Components of a GMP Quality System

Effective GMP programs rely on structured quality systems that govern manufacturing operations from raw materials to final product release.

Quality Management Oversight

Senior management must establish a quality system that defines policies, responsibilities, and oversight mechanisms. For pharmaceutical manufacturers, ICH Q10 describes the model pharmaceutical quality system that regulators expect.

Key governance elements include:

• Documented quality policy and objectives

• Defined responsibilities for quality personnel

• Independent quality assurance authority

• Management review of quality performance

• Continuous improvement mechanisms

Many organizations integrate these functions within broader governance models supported by management system consulting approaches.

Documentation and Record Control

Documentation is one of the most critical GMP requirements.

Manufacturers must maintain controlled records demonstrating how products were produced and tested.

Examples include:

• Standard operating procedures (SOPs)

• Batch manufacturing records

• Equipment logs

• Cleaning records

• Training documentation

• Change control documentation

Accurate documentation allows regulators to reconstruct the entire manufacturing history of a product batch.

Records must also meet data integrity expectations, commonly summarized as ALCOA+: data should be attributable, legible, contemporaneous, original, and accurate, as well as complete, consistent, enduring, and available. Electronic records used to meet FDA requirements fall under 21 CFR Part 11, and regulators treat data integrity failures as serious GMP violations.

Facility and Equipment Controls

GMP regulations require manufacturing facilities and equipment to be properly designed, maintained, and controlled.

Common requirements include:

• Environmental controls for contamination prevention

• Equipment calibration and maintenance programs

• Controlled material flow and storage areas

• Segregation of raw materials and finished goods

• Facility cleaning and sanitation procedures

Process design must minimize risks of cross-contamination and operational errors.

Personnel Qualification and Training

Manufacturing personnel must be properly trained and qualified for their assigned roles.

Training programs must address:

• GMP regulatory requirements

• Standard operating procedures

• Equipment operation

• Contamination control

• Documentation practices

Organizations frequently formalize workforce capability programs through Providing a Learning Service initiatives that ensure consistent competency development.

Process Validation

Process validation demonstrates that a manufacturing process consistently produces product meeting its quality specifications. FDA's process validation guidance for drugs describes validation as a lifecycle with three stages:

1. Process design: defining the commercial process based on development and scale-up knowledge.

2. Process qualification: confirming the process performs as designed at commercial scale.

3. Continued process verification: ongoing monitoring to show the process remains in a state of control.

As part of qualification, the equipment and utilities used in the process are typically qualified through:

• Installation qualification (IQ)

• Operational qualification (OQ)

• Performance qualification (PQ)

Validation evidence is essential during regulatory inspections.

Quality Control and Product Release

Quality control laboratories and testing programs confirm that products meet defined specifications before release.

Testing activities may include:

• Raw material verification

• In-process testing

• Finished product analysis

• Stability testing

Quality assurance personnel must review documentation and testing results before authorizing product release.

Deviations, CAPA, and Change Control

A GMP quality system must detect problems, correct them, and prevent them from recurring, and it must control changes before they reach production.

Key elements include:

• Deviation and nonconformance investigations with documented root cause analysis

• Corrective and preventive actions (CAPA) with effectiveness checks

• Change control that evaluates the quality and regulatory impact of a change before it is implemented

• Complaint handling and recall procedures

• Supplier qualification and ongoing monitoring of material suppliers and contract manufacturers

Inspectors often follow a single deviation through investigation, CAPA, and change control to judge whether the quality system works in practice.

GMP Inspections and Regulatory Enforcement

Regulatory agencies conduct routine and for-cause inspections to verify compliance with GMP regulations.

During inspections, regulators evaluate whether manufacturers are operating controlled quality systems.

Inspectors typically review:

• Quality system documentation

• Manufacturing records

• Validation data

• Equipment maintenance records

• Training documentation

• Deviation and corrective action records

When FDA investigators observe objectionable conditions, they issue a Form FDA 483 listing their observations at the close of the inspection. Serious or unresolved findings can escalate to warning letters, import alerts, product recalls, or consent decrees.

Organizations must demonstrate not only that procedures exist but that they are consistently followed in practice.

Many manufacturers conduct internal readiness assessments through audit readiness consulting to identify compliance gaps before regulatory inspections occur.

Relationship Between GMP and ISO Management Systems

Although GMP regulations are mandatory in regulated industries, many organizations implement ISO-based management systems to strengthen governance and operational discipline.

For example:

• ISO frameworks improve documentation control and process standardization

• Internal audit structures improve inspection readiness

• Corrective action systems strengthen root cause analysis

• Risk management practices enhance preventive controls

For medical device manufacturers, the relationship is now direct: FDA's QMSR incorporates ISO 13485:2016 by reference, so a well-structured ISO 13485 Implementation aligns a device quality system with U.S. requirements. ISO 13485 certification does not replace FDA inspection, however, and the QMSR retains some FDA-specific requirements.

Integration of GMP and ISO management systems reduces duplication and creates a unified operational governance structure.

Benefits of Good Manufacturing Practice

Organizations that implement disciplined GMP programs gain significant operational and regulatory advantages.

Key benefits include:

• Reduced product contamination and safety risks

• Improved manufacturing consistency and reliability

• Stronger regulatory compliance posture

• Faster investigation of product deviations

• Enhanced product traceability and recall readiness

• Increased customer confidence and market credibility

Strong GMP programs also improve internal operational efficiency by standardizing processes and documentation practices.

Many organizations extend these programs into broader Maintaining a System initiatives to ensure long-term compliance maturity and continual improvement.

Common GMP Compliance Challenges

Organizations frequently struggle with GMP compliance when quality systems are poorly structured or inconsistently implemented.

Common challenges include:

• Incomplete or inconsistent documentation practices

• Weak change control processes

• Poorly maintained equipment records

• Insufficient training documentation

• Weak supplier qualification programs

• Lack of independent quality oversight

These issues often emerge during regulatory inspections and can lead to warning letters, product recalls, or enforcement actions.

Disciplined process design and governance structures are essential to maintaining sustainable compliance.

Is GMP Certification Required?

Unlike ISO standards, GMP is not a voluntary certification standard. It is a legal requirement for regulated products, and compliance is verified through inspections conducted by government authorities such as FDA.

Some regulators document inspection outcomes formally; national competent authorities in the European Union, for example, issue GMP certificates to sites that pass inspection. Third-party GMP audit and certification programs also exist, and customers may require them, but they do not replace regulatory inspection.

Many organizations also pursue ISO-based quality system certification alongside their GMP programs to demonstrate operational maturity and audit readiness.

How to Build or Strengthen a GMP Program

Whether a manufacturer is preparing for its first inspection or responding to findings, GMP programs are typically built or repaired in this sequence:

1. Confirm applicable requirements: identify which regulations apply based on product type and the markets you sell into.

2. Assess the current state: compare existing procedures, records, and practices against those requirements.

3. Prioritize by risk: address gaps that affect product safety, data integrity, and release decisions first.

4. Implement controls: write or revise procedures, qualify equipment, validate processes, and train personnel.

5. Verify through internal audit: test the system the way an inspector would, before an inspection happens.

6. Maintain and improve: use management review, CAPA trends, and internal audits to keep the system current.

For support at any stage, from readiness assessment through implementation, see our GMP compliance consulting services.

The Strategic Role of GMP in Modern Manufacturing

Good Manufacturing Practice is not merely a regulatory obligation — it is the operational backbone of regulated manufacturing industries.

Effective GMP systems ensure that product quality is designed into the manufacturing process, supported by documented procedures, validated processes, trained personnel, and controlled environments.

Organizations that treat GMP as a strategic governance system — rather than a compliance checklist — achieve stronger operational reliability, regulatory confidence, and long-term market credibility.

Good Manufacturing Practice: Common Questions

What is the difference between GMP and CGMP?

They refer to the same requirements. CGMP, or current Good Manufacturing Practice, is the term FDA uses in its regulations, and "current" signals that manufacturers must keep their systems and technologies up to date. Outside the U.S., GMP is the more common term.

Does GMP still apply if we outsource manufacturing?

Yes. Outsourcing production does not transfer regulatory responsibility. The company that markets the product remains accountable for its quality and must qualify and oversee its contract manufacturers and testing laboratories, typically under a written quality agreement.

Is ISO 9001 certification enough to meet GMP requirements?

No. ISO 9001 provides a strong management system foundation, but it does not include product-specific GMP controls such as batch records, process validation, and quality unit release authority. Medical device manufacturers are a partial exception, because the QMSR incorporates ISO 13485, a device-specific standard, though FDA-specific requirements still apply.

How often does FDA inspect GMP facilities?

There is no fixed schedule. FDA prioritizes inspections based on risk factors such as product type, compliance history, and time since the last inspection, and it can conduct for-cause inspections in response to complaints, recalls, or other signals. Facilities should operate as if an inspection could happen at any time.

If You’re Also Evaluating…

• Pharmaceutical GMP Compliance

• GMP Compliance Consulting

• FDA QMSR Consultant

• ISO 13485 Consultant Services

• Dietary Supplement GMP

Organizations implementing GMP programs often begin with a structured regulatory readiness assessment followed by a controlled quality system implementation roadmap aligned with applicable regulatory frameworks.